Clicky

Innate Pharma(IPH) News

Date Title
Jul 25 Number of Shares and Voting Rights of Innate Pharma as of July 10, 2024
Jun 18 Number of Shares and Voting Rights of Innate Pharma as of June 10, 2024
Jan 12 Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024
Dec 19 Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Dec 10 Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Patients With Sézary Syndrome at ASH 2023
Nov 27 Innate Pharma to Host Virtual KOL Event on Lacutamab
Nov 7 Innate Pharma Announces Conference Call for Third Quarter 2023 Business Update
Jul 11 First Patient Dosed in SAR’514 / IPH6401 Phase 1/2 Clinical Trial in Relapsed/Refractory Multiple Myeloma
Jul 7 Number of Shares and Voting Rights of Innate Pharma as of July 1, 2023